Baker Brothers Advisors - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 109 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,524,000
+25.9%
75,3570.0%0.02%
+38.9%
Q3 2016$2,005,000
+20.6%
75,3570.0%0.02%
+5.9%
Q2 2016$1,662,000
-24.9%
75,3570.0%0.02%
-26.1%
Q1 2016$2,213,000
-11.1%
75,3570.0%0.02%
+9.5%
Q4 2015$2,488,000
-8.6%
75,3570.0%0.02%
-16.0%
Q3 2015$2,723,000
-19.7%
75,3570.0%0.02%
-16.7%
Q2 2015$3,390,000
+46.9%
75,3570.0%0.03%
+57.9%
Q1 2015$2,307,000
-39.8%
75,3570.0%0.02%
-51.3%
Q4 2014$3,832,000
+28.5%
75,3570.0%0.04%
+2.6%
Q3 2014$2,982,000
-8.1%
75,3570.0%0.04%
-5.0%
Q2 2014$3,246,000
+0.3%
75,357
-6.9%
0.04%
-2.4%
Q1 2014$3,237,000
+8.8%
80,957
-25.8%
0.04%
-2.4%
Q4 2013$2,976,000
+3.9%
109,097
-12.7%
0.04%
+2.4%
Q3 2013$2,865,000
+29.4%
125,0000.0%0.04%
-6.8%
Q2 2013$2,214,000125,0000.04%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders